Calidi Biotherapeutics, Inc. Quarterly Other Liabilities, Noncurrent in USD from Q3 2023 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Calidi Biotherapeutics, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q3 2023 to Q4 2023.
  • Calidi Biotherapeutics, Inc. Other Liabilities, Noncurrent for the quarter ending December 31, 2023 was $1.5M.
Other Liabilities, Noncurrent, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.5M Dec 31, 2023 10-K 2024-03-15
Q3 2023 $508K Sep 30, 2023 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.